If approved, Aphria says it expects Shoppers Drug Mart will sell Aphria-branded cannabis products online. (more…)
Tag Archives: medical marijuana and pharmaceutical sector
The body’s natural cannabinoid system, the endocannabinoid system, plays a major role in regulating anxiety throughout the body. (more…)
Analysts have estimated that Epidiolex could be a $1 billion drug for GW Pharmaceuticals. (more…)
The businesses have 15 days to submit evidence to the F.D.A. that they have corrected the violations or to explain..
Many people have advocated using medical marijuana as an alternative for prescription opioids. But now researchers at the University of Florida will..
Anxiety disorders are the most common mental illness in the US. An estimated 40 million American adults, or just over 18%..
Hemp businesses are closely watching as the drug Epidiolex, made by GW Pharmaceuticals, moves through the FDA approval pipeline. (more…)
Many older adults use marijuana to help with chronic pain, an ailment that becomes more common with age. Others use..
Research into the potential medical uses of marijuana compounds continues apace. Among the most recent, a study delved into why..
British cannabis-derived medicines company GW Pharma is planning to gear up its plant growing and processing operations in the UK..
Plenty of accounts by healthcare providers demonstrate that medicinal use of marijuana helps seniors with pain, anxiety, nausea during chemotherapy..
Pharmaceutical companies are intrigued by the immense and growing medical marijuana market but cannot figure a way to corner it...
